Zhuo Y

No ORCID on file · 6 papers in corpus
other 2023
Frontiers in pharmacology ·doi:10.3389/fphar.2023.1254518

[This corrects the article DOI: 10.3389/fphar.2023.1199010.].

2023
Open life sciences ·doi:10.1515/biol-2022-0670

This study aimed to investigate effects of pulmonary fractalkine (FKN/CX3CL1) on angiogenesis and tube formation. Tube forming capability of pulmonary vascular endothelial cells (PVECs) was evaluated. CCK-8 assay was used to evaluate prolif…

2023
EMBO molecular medicine ·doi:10.15252/emmm.202216373

The pathological retinal angiogenesis often causes blindness. Current anti-angiogenic therapy for proliferative retinopathy targets the vascular endothelial growth factor (VEGF), but many patients do not radically benefit from this therapy.…

review 2023
Frontiers in pharmacology ·doi:10.3389/fphar.2023.1199010

Endometriosis is one of the most common benign gynecological disorders in reproductive-aged women. The major symptoms are chronic pelvic pain and infertility. Despite its profound impact on women's health and quality of life, its pathogenes…

2022
Medicine ·doi:10.1097/md.0000000000029155

BackgroundPrimary dysmenorrhea (PD) is a painful disease that severely affects the daily lives of young women. External therapy using traditional Chinese medicine (TCM) is widely used in the clinical treatment of this disease and has achiev…

2021
Frontiers in pharmacology ·doi:10.3389/fphar.2021.735079

Chronic pancreatitis (CP) is a progressive fibro-inflammatory syndrome. The damage of acinar cells is the main cause of inflammation and the activation of pancreatic stellate cells (PSCs), which can thereby possibly further aggravate the ap…